Researchers from the University of Edinburgh and the Spanish National Research Council have harnessed the power of artificial intelligence (AI) to discover three potent molecules that could potentially slow down the ageing process. The study, led by Integrated Biosciences, a biotechnology company dedicated to ageing research, demonstrates the tremendous potential of AI in uncovering novel senolytic compounds capable of suppressing age-related processes such as fibrosis, inflammation, and cancer.
AI and anti-aging research: Unveiling the latest drug discovery
Frontiers Artificial intelligence-driven systems engineering for next-generation plant-derived biopharmaceuticals
Bioactive leads for skin aging—Current scenario and future perspectives - ScienceDirect
Artificial intelligence: Unexpected results - Cheminformatics take a look behind the scenes of machine learning in drug research
AI revolutionises ageing research: Promising anti-aging compounds discovered - The Week
Artificial intelligence in COVID-19 drug repurposing - ScienceDirect
Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design. - Abstract - Europe PMC
Artificial intelligence (AI) and machine learning (ML) project
AI Finds Drug Candidates To Target Aging-Associated Cells
